alaeloa,
IMO, no, a share buy back will not happen. ACT has 2 trials in progress, one approved to for the UK yesterday, and upcoming IND filings in other areas. ACT will need cash and lots of it especially when entering the larger Phase 2 studies, especially for dryAMD.
Many things are in play now with Corporate. We are very close to maxing out the AS# of 1.75B. They will need to ask shareholders to vote for an increase. In Rodman conference presentation Rabin stated a national exchange is "front of mind". Rabin has stated prior the only thing holding ACT back from an uplist is the price per share. There are 2 ways to get the price per share up to approx. $4/shares needed to uplist.
1)ACT does it on their own with news
2)reverse split
